Sanofi (NASDAQ:SNY) Plans Dividend Increase – $1.48 Per Share

Sanofi (NASDAQ:SNY) declared an annual dividend on Tuesday, March 26th, Zacks reports. Shareholders of record on Friday, May 10th will be given a dividend of 1.478 per share on Thursday, June 6th. This represents a yield of 2.98%. The ex-dividend date of this dividend is Thursday, May 9th. This is a positive change from Sanofi’s previous annual dividend of $1.38.

Sanofi has increased its dividend by an average of 3.8% per year over the last three years and has raised its dividend every year for the last 2 years. Sanofi has a payout ratio of 43.3% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Sanofi to earn $4.66 per share next year, which means the company should continue to be able to cover its $2.04 annual dividend with an expected future payout ratio of 43.8%.

Sanofi Price Performance

Shares of SNY stock opened at $49.57 on Wednesday. The firm’s 50 day moving average price is $47.92 and its two-hundred day moving average price is $48.14. The stock has a market cap of $125.39 billion, a PE ratio of 24.91, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.87 and a current ratio of 1.27. Sanofi has a 52-week low of $42.63 and a 52-week high of $55.72.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. TheStreet cut shares of Sanofi from a “b” rating to a “c” rating in a research report on Friday, February 9th. StockNews.com cut shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Morgan Stanley began coverage on shares of Sanofi in a research note on Tuesday, January 23rd. They issued an “equal weight” rating and a $55.00 price objective for the company. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $55.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.